Fulvio Adorni
- Virology top 1%
- HIV Research and Treatment 23
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 24
- HIV/AIDS Research and Interventions 17
- Emergency Medicine top 2%
- HIV-related health complications and treatments 11
- Physiology top 5%
- Epidemiology top 5%
- Respiratory viral infections research 11
-
- Nutritional Studies and Diet 6
-
- Neonatal Respiratory Health Research 6
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
- Co-authors
- Massimo MusiccoFederica PrinelliSimona Gabriella Di SantoMassimo GalliCarlo CaltagironeAntonella d’Arminio MonforteCarla PettenatiAntonio Russo
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Fulvio Adorni
83 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 135
- Virology 455
- Infectious Diseases 805
- Emergency Medicine 305
- Physiology 416
- Epidemiology 519
Countries citing papers authored by Fulvio Adorni
This map shows the geographic impact of Fulvio Adorni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fulvio Adorni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fulvio Adorni more than expected).
Fields of papers citing papers by Fulvio Adorni
This network shows the impact of papers produced by Fulvio Adorni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fulvio Adorni. The network helps show where Fulvio Adorni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fulvio Adorni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 18 | |
| 4 | 2022 | 6 | |
| 5 | 2021 | 43 | |
| 6 | 2021 | 22 | |
| 7 | 2021 | 14 | |
| 8 | 2020 | 28 | |
| 9 | 2020 | 7 | |
| 10 | 2020 | 58 | |
| 11 | 2019 | 27 | |
| 12 | Exposure to vehicular traffic is associated to a higher risk of hospitalization for bronchiolitis during the first year of life. | 2016 | 2 |
| 13 | 2014 | 2 | |
| 14 | 2013 | 10 | |
| 15 | 2009 | 68 | |
| 16 | 2007 | 23 | |
| 17 | 2007 | 14 | |
| 18 | 2006 | 14 | |
| 19 | 2001 | 4 | |
| 20 | Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer. | 2000 | 36 |
About Fulvio Adorni
Fulvio Adorni is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 86 papers that have together received 2.4k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (23 papers), HIV/AIDS Research and Interventions (17 papers), HIV-related health complications and treatments (11 papers), Respiratory viral infections research (11 papers), Nutritional Studies and Diet (6 papers), Neonatal Respiratory Health Research (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). The work is most often cited by research in Virology (455 citations), Infectious Diseases (805 citations) and Emergency Medicine (305 citations). Fulvio Adorni has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Massimo Musicco, Federica Prinelli, Simona Gabriella Di Santo, Massimo Galli, Carlo Caltagirone, Antonella d’Arminio Monforte, Carla Pettenati, Antonio Russo, Anna Lisa Ridolfo and Katie Palmer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.